MyPeptide

Research Use Only

Confirm access requirements before entering MyPeptide.

MyPeptide

Loading MyPeptide

GH Axis Research · 8 min read

Secretagogue Research: GHRH and GHRP Synergy at the Pituitary

Research is revealing how GH-axis secretagogues support natural GH signalling pathways — without suppressing endogenous production.

Why secretagogue research is advancing beyond direct GH replacement.

MK-677 (Ibutamoren) is a non-peptide, orally active ghrelin mimetic that sustains GH and IGF-1 elevation over 24 hours from a single dose. Multiple published studies over 2+ years demonstrate sustained effects on metabolic biomarkers, circadian quality metrics, and bone density.

Each MyPeptide reference page is organized around product identity, documentation, and research context rather than medical claims, dosing instructions, or personal-use outcomes.

Use the related links on this page to move between the catalog, COA records, policy pages, and supporting research guides while staying within the research-use-only scope.

Batch documentation, product identity, and compliance context are kept close together so qualified purchasers can review the material before continuing through the storefront.

Article sections

  • GH-Axis Secretagogue Research: Preserving Natural GH Signalling
  • Research Context
  • Oral GH Secretagogue (MK-677)
  • Selective GH Release (Ipamorelin)
  • Synergistic Dual-Pathway (CJC-1295/Ipamorelin)